NIT
CHRS icon

NumerixS Investment Technologies’s Coherus Oncology CHRS Stock Holding History

NumerixS Investment Technologies’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,400
Closed -$61K – 162
2020
Q2 		$61K Buy
+3,400
New +$57.5K 0.02% 740
2020
Q1 		– Sell
-7,806
Closed -$141K – 1034
2019
Q4 		$141K Buy
+7,806
New +$144K 0.03% 589
2017
Q4 		– Sell
-16,800
Closed -$224K – 1157
2017
Q3 		$224K Buy
16,800
+9,300
+124% +$123K 0.05% 485
2017
Q2 		$108K Sell
7,500
-6,500
-46% -$125K 0.02% 813
2017
Q1 		$296K Buy
+14,000
New +$344K 0.03% 594
2016
Q4 		– Sell
-6,300
Closed -$169K – 1147
2016
Q3 		$169K Buy
+6,300
New +$172K 0.02% 728

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NumerixS Investment Technologies's CHRS Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Coherus Oncology (CHRS) in Q3 2020, closing a stake of 3,400 shares — an estimated $61K sold.

NumerixS Investment Technologies first reported a position in CHRS in Q3 2016 and held it in 6 quarters. The position peaked at $296K in Q1 2017. 201 funds tracked by Wall St. Rank hold CHRS as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Coherus Oncology position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,400 Coherus Oncology shares in Q3 2020, an estimated $61K.
  • NumerixS Investment Technologies first reported a position in Coherus Oncology in Q3 2016 and held it in 6 quarters.
  • NumerixS Investment Technologies's Coherus Oncology position peaked at $296K in Q1 2017.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.